NeoMedLight
Villeurbanne
About NeoMedLight
NeoMedLight develops innovative medical devices designed for phototherapy. The company is the owner of a unique and proprietary technology: the emission of light through woven optic fibers, the Fabric of Light (Lightex®). This technology was originally developed by Brochier Technologies (www.brochiertechnologies.com) with which NeoMedLight shares the overall ownership. NeoMedLight has the exclusivity in healthcare. The company has initially conceived and developed a fiber-optic phototherapy device to treat neonatal jaundice; Further therapeutic indications that would benefit from the Fabric of Light may include mucositis, dermatitis, wound healing/tissue regeneration, as well as pain management. The objective of NeoMedLight® is to bring the innovation to all therapeutic fields in which it will benefit patients and healthcare providers.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $3.3M
- Last round: Grant (Aug 2018)
- Website: neomedlight.com
- Phone: +33 (0)9 72 48 26 25
Industries & Categories
Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/neomedlight-161690 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.